PipelinePharma Logo

oxybutynin Syrup 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
Egypt
Manufacturer #20788

This CTD dossier owner and manufacturer, established in the late 1990s, has a strong presence in the global pharmaceutical market. They specialize in developing and manufacturing a wide range of prescription and over-the-counter medications, encompassing various therapeutic areas. With over 250 products currently available and 50 in development, the company boasts a diverse portfolio covering a wide range of dosage forms, including solids, liquids, and injectables. Their extensive production lines are compliant with both EU and US GMP standards, demonstrating a commitment to quality and safety. The company has a significant presence in multiple regions, including North America and Europe. Their track record demonstrates a dedication to scientific innovation and a focus on producing high-quality healthcare solutions.

Oxybutynin is a medication used to treat overactive bladder. Suppliers market it as oxybutynin oral tablets, transdermal patches, topical gels and it is available as immediate and delayed-release formulations. The drug was first approved for medical use in 1975, and by now has reached widespread use, with over 6 million prescriptions registered yearly in the U.S. alone. Multiple manufacturing companies and drug vendors populate the global oxybutynin market, including major suppliers such as Sanofi-Aventis, Mylan, Accord Healthcare, and many others. Suppliers market both generic and trade name oxybutynin medications. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. The retail prices per 60 (5mg) tablets of oxybutynin fall into an approximate range of 7.50 EUR to 10.00 EUR.